Pharmacology and the Nursing Process Practice Exam 2026 – The Comprehensive All-in-One Guide to Master Your Exam!

Omalizumab is a type of monoclonal antibody antiasthmatic drug. This means that it is a drug that specifically targets and binds to certain components of the immune system to treat asthma.

Option A, phosphodiesterase 4 inhibitor, is incorrect because this type of drug is used to treat conditions such as chronic obstructive pulmonary disease and not specifically asthma.

Option B, corticosteroid, is incorrect because while it is also used to treat asthma, it works by reducing inflammation in the airways rather than targeting specific components of the immune system.

Option D, anticoagulant, is incorrect because this type of drug is used to prevent blood clots and has no relation to treating asthma.